Molecular and Clinicopathological Characteristics Predict Fertility-Sparing Treatment Outcomes in Endometrial Atypical Hyperplasia and Endometrioid Endometrial Cancer.
Rising incidence of endometrial cancer among young women has increased the demand for fertility-sparing treatment (FST) in patients with endometrial atypical hyperplasia (EAH) and endometrioid endometrial cancer (EEC). However, approximately 20%-30% of patients exhibit progesterone resistance, and reliable predictive b...